Hangzhou Biotest Biotech Co Ltd (688767) — Tangible Net Worth Ratio
Hangzhou Biotest Biotech Co Ltd (688767) has a Tangible Net Worth Ratio of 88.7% as of March 2026. This metric is calculated by deducting intangible assets (CN¥267.89 Million) from net assets (CN¥2.36 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Hangzhou Biotest Biotech Co Ltd (688767) net asset momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Hangzhou Biotest Biotech Co Ltd Tangible Net Worth Ratio (2017–2025)
This chart shows how Hangzhou Biotest Biotech Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 88.7%, reflecting net assets of CN¥2.36 Billion with intangible assets of CN¥267.89 Million CNY. For live market cap and overall valuation, see market cap of Hangzhou Biotest Biotech Co Ltd.
Annual Tangible Net Worth Ratio for Hangzhou Biotest Biotech Co Ltd (2017–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Hangzhou Biotest Biotech Co Ltd from 2017 to 2025, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Hangzhou Biotest Biotech Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.6% | CN¥2.37 Billion | CN¥269.31 Million | CN¥2.54 Billion | ▲ +0.0 pp |
| 2024 | 88.6% | CN¥2.41 Billion | CN¥275.16 Million | CN¥2.60 Billion | ▼ -2.8 pp |
| 2023 | 91.4% | CN¥2.42 Billion | CN¥208.71 Million | CN¥2.58 Billion | ▼ -0.3 pp |
| 2022 | 91.7% | CN¥2.56 Billion | CN¥213.71 Million | CN¥2.75 Billion | ▼ -7.4 pp |
| 2021 | 99.0% | CN¥2.11 Billion | CN¥20.35 Million | CN¥2.43 Billion | ▲ +3.7 pp |
| 2020 | 95.3% | CN¥443.02 Million | CN¥20.75 Million | CN¥633.92 Million | ▲ +12.2 pp |
| 2019 | 83.1% | CN¥125.95 Million | CN¥21.33 Million | CN¥210.44 Million | ▲ +5.1 pp |
| 2018 | 78.0% | CN¥98.15 Million | CN¥21.58 Million | CN¥154.63 Million | ▲ +5.6 pp |
| 2017 | 72.4% | CN¥79.63 Million | CN¥21.99 Million | CN¥127.52 Million | — |